Liang Guohai, Han Jiamei, Hao Qiubo
MOE Key Laboratory of Laser Life Science & Institute of Laser Life Science, South China Normal University, Guangzhou 510631, China.
College of Biophotonics, South China Normal University, Guangzhou 510631, China.
ACS Appl Bio Mater. 2018 Nov 19;1(5):1389-1397. doi: 10.1021/acsabm.8b00346. Epub 2018 Oct 11.
Extremely small-sized iron oxide nanoparticles (ESIONs) have been accepted as a potential alternative to gadolinium-based contrast agents for enhanced -weighted MR imaging. Recently developed zwitterion-coated ESIONs showed a high contrast power and efficient renal clearing ability, but the tedious preparation steps that required high-cost, unfriendly experimental conditions and a sophisticated phase transition process would likely hinder their clinical translation. Herein, we present a one-pot gram-scale synthesis of zwitterion-capped ultrasmall iron oxide nanoparticles (ZUIONs). The nanoparticles have a core size as small as 3.7 nm and display high colloidal stability in various buffers. The relaxivity of 2.4 mM s and / ratio as low as 2.2 at 1.0 T guarantee their application as effective MRI contrast agents. In vivo studies showed that ZUIONs could induce a significant contrast enhancement in blood pool and be eliminated from the body mainly through the renal excretion pathway. The combined advantageous features including facile preparation, excellent biocompatibility, strong MRI contrast effect, appropriate circulation time, and renal clearable property would render ZUIONs attractive for practical applications.
极小型氧化铁纳米颗粒(ESIONs)已被公认为是钆基造影剂用于增强加权磁共振成像的一种潜在替代品。最近开发的两性离子包覆的ESIONs显示出高对比能力和高效的肾脏清除能力,但繁琐的制备步骤需要高成本、不友好的实验条件以及复杂的相变过程,这可能会阻碍它们的临床转化。在此,我们展示了一种一锅法克级合成两性离子封端的超小型氧化铁纳米颗粒(ZUIONs)。这些纳米颗粒的核心尺寸小至3.7纳米,并且在各种缓冲液中表现出高胶体稳定性。在1.0 T时,弛豫率为2.4 mM s且/比率低至2.2,保证了它们作为有效的MRI造影剂的应用。体内研究表明,ZUIONs可在血池中诱导显著的对比增强,并且主要通过肾脏排泄途径从体内清除。包括制备简便、优异的生物相容性、强大的MRI对比效果、适当的循环时间和肾脏可清除特性等综合优势将使ZUIONs在实际应用中具有吸引力。